These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1715730)

  • 1. Immunocytochemistry of cytokeratins in primary human liver tumors.
    Van Eyken P; Sciot R; Desmet VJ
    APMIS Suppl; 1991; 23():77-85. PubMed ID: 1715730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas.
    Lai YS; Thung SN; Gerber MA; Chen ML; Schaffner F
    Arch Pathol Lab Med; 1989 Feb; 113(2):134-8. PubMed ID: 2464975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver.
    Brunt EM; Swanson PE
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S53-61. PubMed ID: 1374219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.
    Uenishi T; Kubo S; Hirohashi K; Yamamoto T; Ogawa M; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1101-4. PubMed ID: 12845990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
    Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
    Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrins as differential cell lineage markers of primary liver tumors.
    Volpes R; van den Oord JJ; Desmet VJ
    Am J Pathol; 1993 May; 142(5):1483-92. PubMed ID: 7684197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects.
    Fischer HP; Altmannsberger M; Weber K; Osborn M
    Am J Pathol; 1987 Jun; 127(3):530-7. PubMed ID: 2438941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T; Hoso M; Nakanuma Y
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cytokeratin-immunohistochemical study of hepatoblastoma.
    Van Eyken P; Sciot R; Callea F; Ramaekers F; Schaart G; Desmet VJ
    Hum Pathol; 1990 Mar; 21(3):302-8. PubMed ID: 1690171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study.
    Van Eyken P; Sciot R; Paterson A; Callea F; Kew MC; Desmet VJ
    Hum Pathol; 1988 May; 19(5):562-8. PubMed ID: 2453442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible relation between histone 3 and cytokeratin 18 in human hepatocellular carcinoma.
    Ho CC; Cheng CC; Liu YH; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
    In Vivo; 2008; 22(4):457-62. PubMed ID: 18712172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appearance of fibronectin in putative preneoplastic lesions and in hepatocellular carcinoma during chemical hepatocarcinogenesis in rats and in human hepatomas.
    Szendröi M; Lapis K; Zalatnai A; Robert L; Labat-Robert J
    J Exp Pathol; 1984; 1(3):189-99. PubMed ID: 6100983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
    Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
    Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of alpha 1-antitrypsin in hepatomas.
    Reintoft I; Hägerstrand I
    Arch Pathol Lab Med; 1979 Sep; 103(10):495-8. PubMed ID: 223516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic diagnosis of hepatic tumors.
    Goodman ZD
    Ann Clin Lab Sci; 1984; 14(3):169-78. PubMed ID: 6329068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.